Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Fagan

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Neurology|July 13, 2006
Neuroprotective agents for clinical trials in ALS: a systematic assessmentB J Traynor, L Bruijn, R Conwit, et al.
Journal of Toxicology and Environmental Health|June 1, 1995
Neurobehavioral and physiologic effects of trifluoromethane in humansS C Fagan, A A Rahill, G Balakrishnan, et al.
Journal of Toxicology and Environmental Health|September 1, 1994
Evaluation of the acute cardiac and central nervous system effects of the fluorocarbon trifluoromethane in baboonsC A Branch, D A Goldberg, J R Ewing, et al.
Pharmacoeconomics|November 10, 2001
Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspectiveS E Sinclair, L Frighetto, P S Loewen, et al.
The Annals of Pharmacotherapy|February 1, 1993
Labetalol: response and safety in critically ill hemorrhagic stroke patientsR V Patel, H R Kertland, B E Jahns, et al.
DICP : the Annals of Pharmacotherapy|December 1, 1991
Assessing the effects of antihypertensive medication on cerebral blood flow: demonstration in internal carotid artery occlusionS C Fagan, J R Ewing, S R Levine, et al.
The Annals of Pharmacotherapy|November 1, 1996
Current developments in neurology, Part I: Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosisB E Gidal, M L Wagner, M D Privitera, et al.
Neurology|April 23, 2003
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessmentB M Ravina, S C Fagan, R G Hart, et al.
The Annals of Pharmacotherapy|December 1, 1996
Current developments in neurology, Part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson's disease, and strokeB E Gidal, M L Crismon, M L Wagner, et al.
Stroke|January 1, 1990
Fluorocarbon-23 measure of cat cerebral blood flow by nuclear magnetic resonanceJ R Ewing, C A Branch, S C Fagan, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Neurology|July 13, 2006
Neuroprotective agents for clinical trials in ALS: a systematic assessmentB J Traynor, L Bruijn, R Conwit, et al.
Journal of Toxicology and Environmental Health|June 1, 1995
Neurobehavioral and physiologic effects of trifluoromethane in humansS C Fagan, A A Rahill, G Balakrishnan, et al.
Journal of Toxicology and Environmental Health|September 1, 1994
Evaluation of the acute cardiac and central nervous system effects of the fluorocarbon trifluoromethane in baboonsC A Branch, D A Goldberg, J R Ewing, et al.
Pharmacoeconomics|November 10, 2001
Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspectiveS E Sinclair, L Frighetto, P S Loewen, et al.
The Annals of Pharmacotherapy|February 1, 1993
Labetalol: response and safety in critically ill hemorrhagic stroke patientsR V Patel, H R Kertland, B E Jahns, et al.
DICP : the Annals of Pharmacotherapy|December 1, 1991
Assessing the effects of antihypertensive medication on cerebral blood flow: demonstration in internal carotid artery occlusionS C Fagan, J R Ewing, S R Levine, et al.
The Annals of Pharmacotherapy|November 1, 1996
Current developments in neurology, Part I: Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosisB E Gidal, M L Wagner, M D Privitera, et al.
Neurology|April 23, 2003
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessmentB M Ravina, S C Fagan, R G Hart, et al.
The Annals of Pharmacotherapy|December 1, 1996
Current developments in neurology, Part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson's disease, and strokeB E Gidal, M L Crismon, M L Wagner, et al.
Stroke|January 1, 1990
Fluorocarbon-23 measure of cat cerebral blood flow by nuclear magnetic resonanceJ R Ewing, C A Branch, S C Fagan, et al.
Pageof 5